Viatris launches RYZUMVl 0.75% in US

The average time of dilation lasts three to eight hours

Celanese and Secarna Pharmaceuticals collaborate for RNA research for antisense therapies

JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr

JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market

Biocon Biologics completes Integration of Viatris' Biosimilar business

The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone

Biocon Biologics receives MHRA, UK Approval for Biosimilar Aflibercept ‘Yesafili’

Yesafili, received marketing authorization approval from the European Commission for the European Union

Bayer posts Q3 2023 Group sales Euro 10.34 billion

We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”

Mandaviya inaugurates Rural Health Training Centre (RHTC) Hospital in Najafgarh, Delhi

RHTC will address a long-standing healthcare access issue for all the local population

Allergan’s conclave on World Sight Day spotlights eyecare's crucial role in workplace

India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness

Emmes acquires VaxTRIALS

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway